Finch Therapeutics Group Inc (FNCH)
2.24
-0.06
(-2.61%)
USD |
NASDAQ |
Apr 30, 16:00
2.35
+0.11
(+4.91%)
After-Hours: 20:00
Finch Therapeutics Group Shareholders Equity (Quarterly): 22.89M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.89M |
| September 30, 2023 | 25.81M |
| June 30, 2023 | 27.89M |
| March 31, 2023 | 32.95M |
| December 31, 2022 | 95.71M |
| September 30, 2022 | 120.87M |
| June 30, 2022 | 159.09M |
| Date | Value |
|---|---|
| March 31, 2022 | 179.79M |
| December 31, 2021 | 202.22M |
| September 30, 2021 | 219.80M |
| June 30, 2021 | 228.19M |
| March 31, 2021 | 239.46M |
| December 31, 2020 | -95.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-95.72M
Minimum
Dec 2020
239.46M
Maximum
Mar 2021
112.23M
Average
120.87M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 431.76M |
| Vanda Pharmaceuticals Inc | 544.91M |
| Sage Therapeutics Inc | 705.80M |
| BioSig Technologies Inc | -2.913M |
| Palisade Bio Inc | 11.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.37M |
| Total Liabilities (Quarterly) | 32.49M |